glp 1 novo nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry With FDA approval of Wegovy
Description
These symptoms typically occur during treatment initiation or dose escalation and often improve over time, though they can be severe enough to necessitate discontinuation in some patients
Obes Rev 18(1):8698
Their integrated care model ensures optimal drug safety and efficacy for high-risk patients
However, the immediate barriers to adoption of these drugs may lie not in their side effect profile, but rather in the ability of our physicians and healthcare system to accept them
BMC Musculoskelet
